Maintenance Oral Vinorelbine or Observation After Vinorelbine-Docetaxel First Line Chemotherapy in Advanced Breast Ca

NCT02144194 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

65

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Vinorelbine-Docetaxel
DRUG: Vinorelbine

Sponsor

Cancer Research Group - Collaborative Group, Beirut, Lebanon.